These laboratory-developed tests (LDTs) are regulated by the Centers for Medicare and Medicaid (CMS) as high-complexity tests under the Clinical Laboratory Improvement Amendments of 1988 (CLIA 88)
Key pharmacological effects include: Enhanced insulin secretion when blood glucose levels are elevated Reduced glucagon secretion, which decreases hepatic glucose production Delayed gastric emptying, promoting satiety Direct effects on appetite centres in the brain Mounjaro is available in the UK through NHS prescription for eligible patients meeting specific clinical criteria, as outlined by NICE guidance
FODMAPs are found in a variety of foods and can cause digestive symptoms such as bloating, gas, and stomach pain in people with certain digestive disorders, such as irritable bowel syndrome (IBS)
In a phase 2b trial, tirzepatide treatment was associated in a dose-dependent manner with decreased levels of apolipoprotein (apo) B, apoC-III, large triglyceride-rich lipoprotein particles, and small low-density lipoprotein particles, suggesting a shift towards a less atherogenic lipoprotein profile [77]
Some patients achieve therapeutic benefit at lower doses, while others require higher doses to reach target outcomes
Long-term adherence and the potential for weight regain after discontinuing the medication are also important considerations
